Estimated COVID-19 IFR was dozen times higher than flu IFR, whereas COVID-19 CFR was several dozen times higher than flu CFR in USA

Piotr Rieske

doi:10.5114/pja.2020.102088

eISSN: 2391-6052
ISSN: 2353-3854

Alergologia Polska - Polish Journal of Allergology

Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2020
vol. 7

Send email

Copy url:

abstract:

Review paper

Estimated COVID-19 IFR was dozen times higher than flu IFR, whereas COVID-19 CFR was several dozen times higher than flu CFR in USA

Piotr Rieske

¹

Zakład Biologii Nowotworów, Uniwersytet Medyczny w Łodzi

Alergologia Polska – Polish Journal of Allergology 2020; 7, 4: 215–219

DOI: https://doi.org/10.5114/pja.2020.102088

Online publish date: 2020/12/26

View full text Get citation

PlumX metrics:

There is a dispute over whether COVID-19 is more deadly than the flu. Disease mortality does not have to be a parameter that correctly describes the threat. Sometimes population mortality does it better. However this parameter can be calculated after all and does not help to prevent spread of new disease such as COVID-19.Unfortunately, the IFR for influenza is difficult to calculate. Nevertheless, this study makes such an attempt for the USA. This was possible in the case of the USA because it is a country that monitors both diseases relatively well. According to these data, the estimated IFR (infection fatality rate) for COVID-19 was approximately 15 times higher than for influenza, whereas CFR (case fatality rate) was approximately 60 times for COVID-19 than for flu.

keywords:

Estimated COVID-19 IFR was dozen times higher than flu IFR, whereas COVID-19 CFR was several dozen times higher than flu CFR in USA

Piotr Rieske 1

COVD-19, IFR, CFR, flu, SARS-CoV-2

Piotr Rieske

¹